Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa-Reference-Cited by-同舟云学术

Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa

Published:2019-02 Issue:2 Volume:35 Page:129-138
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Chimukangara Benjamin¹²³,Kharsany Ayesha B.M.²,Lessells Richard J.¹,Naidoo Kogieleum²,Rhee Soo-Yon⁴,Manasa Justen⁵,Gräf Tiago¹,Lewis Lara²,Cawood Cherie⁶,Khanyile David⁶,Diallo Karidia⁷,Ayalew Kassahun A.⁷,Shafer Robert W.⁴,Hunt Gillian⁸⁹,Pillay Deenan¹⁰¹¹,Abdool Salim Karim²,de Oliveira Tulio¹²

Affiliation:

1. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

2. Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

3. Department of Virology, National Health Laboratory Service, University of KwaZulu-Natal, Durban, South Africa.

4. Department of Medicine, Stanford University, Stanford, California.

5. Department of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

6. Epicentre AIDS Risk Management (Pty) Limited, Paarl, Cape Town, South Africa.

7. Centers for Disease Control and Prevention (CDC), Pretoria, South Africa.

8. Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), Johannesburg, South Africa.

9. Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

10. Africa Health Research Institute, KwaZulu-Natal, South Africa.

11. Division of Infection and Immunity, University College London, London, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2018.0202

Reference45 articles.

1. Global threat from drug resistant HIV in sub-Saharan Africa

2. Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa

3. Transmission of Drug Resistant HIV and Its Potential Impact on Mortality and Treatment Outcomes in Resource-Limited Settings

4. Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

5. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe;Viruses;2023-09-05

2. Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999–2018;Viruses;2022-09-09

3. HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant Gnidia sericocephala (Thymelaeaceae);Viruses;2022-06-30

4. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-05-26

5. Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis;Clinical Infectious Diseases;2022-03-30